How large databases may impact clinical practices for rare tumors-postoperative chemotherapy in thymic malignancies.
作者信息
Girard Nicolas, Merveilleux du Vignaux Claire
机构信息
Department of Respiratory Medicine and Thoracic Oncology, Hospices Civils de Lyon, Lyon, France.
出版信息
J Thorac Dis. 2016 Aug;8(8):1863-4. doi: 10.21037/jtd.2016.05.65.
Abstract
摘要
相似文献
1
How large databases may impact clinical practices for rare tumors-postoperative chemotherapy in thymic malignancies.大型数据库如何影响罕见肿瘤的临床实践——胸腺恶性肿瘤的术后化疗
J Thorac Dis. 2016 Aug;8(8):1863-4. doi: 10.21037/jtd.2016.05.65.
2
The application of postoperative chemotherapy in thymic tumors and its prognostic effect.术后化疗在胸腺肿瘤中的应用及其预后效果。
J Thorac Dis. 2016 Apr;8(4):696-704. doi: 10.21037/jtd.2016.03.31.
3
Induction therapy for thymic malignancies.胸腺癌的诱导治疗。
Thorac Surg Clin. 2012 Feb;22(1):83-9, vii. doi: 10.1016/j.thorsurg.2011.09.008.
4
Pemetrexed in patients with thymic malignancies previously treated with chemotherapy.培美曲塞用于既往接受过化疗的胸腺恶性肿瘤患者。
Lung Cancer. 2015 Jan;87(1):34-8. doi: 10.1016/j.lungcan.2014.11.006. Epub 2014 Nov 15.
5
Thymoma and thymic carcinoma in children and adolescents: a report from the European Cooperative Study Group for Pediatric Rare Tumors (EXPeRT).儿童和青少年胸腺瘤和胸腺癌：来自儿童罕见肿瘤欧洲合作研究组（EXPeRT）的报告。
Eur J Cancer. 2015 Nov;51(16):2444-52. doi: 10.1016/j.ejca.2015.06.121. Epub 2015 Aug 7.
6
Development of the international thymic malignancy interest group international database: an unprecedented resource for the study of a rare group of tumors.国际胸腺癌兴趣小组国际数据库的开发：为研究一组罕见肿瘤提供了前所未有的资源。
J Thorac Oncol. 2014 Oct;9(10):1573-8. doi: 10.1097/JTO.0000000000000269.
7
Positron Emission Tomography in Thymic Tumors: Analysis Using a Prospective Research Database.胸腺肿瘤的正电子发射断层扫描：使用前瞻性研究数据库进行分析
Ann Thorac Surg. 2017 Dec;104(6):1815-1820. doi: 10.1016/j.athoracsur.2017.06.053. Epub 2017 Oct 21.
8
[Thymic tumors].[胸腺瘤]
Rev Prat. 2017 Apr;67(4):430-434.
9
Chemotherapy and targeted agents for thymic malignancies.胸腺癌的化疗和靶向药物治疗。
Expert Rev Anticancer Ther. 2012 May;12(5):685-95. doi: 10.1586/era.12.29.
10
Proton therapy for thymic malignancies: multi-institutional patterns-of-care and early clinical outcomes from the proton collaborative group and the university of Florida prospective registries.质子治疗胸腺癌：质子协作组和佛罗里达大学前瞻性注册中心的多机构治疗模式和早期临床结果。
Acta Oncol. 2019 Jul;58(7):1036-1040. doi: 10.1080/0284186X.2019.1575981. Epub 2019 Feb 20.
引用本文的文献
1
The role of induction therapy for thymic malignancies: a narrative review.诱导治疗在胸腺恶性肿瘤中的作用：一项叙述性综述。
Mediastinum. 2020 Dec 30;4:36. doi: 10.21037/med-20-20. eCollection 2020.
2
Activation of the mTOR/ Akt pathway in thymic epithelial cells derived from thymomas.胸腺瘤来源的胸上皮细胞中 mTOR/Akt 通路的激活。
PLoS One. 2019 Mar 21;14(3):e0197655. doi: 10.1371/journal.pone.0197655. eCollection 2019.
3
Intra-Thoracic Chemo-Hyperthermia for pleural recurrence of thymomas.胸内化疗热疗治疗胸腺瘤胸膜复发
J Thorac Dis. 2017 Dec;9(12):E1137-E1139. doi: 10.21037/jtd.2017.11.70.
本文引用的文献
1
The application of postoperative chemotherapy in thymic tumors and its prognostic effect.术后化疗在胸腺肿瘤中的应用及其预后效果。
J Thorac Dis. 2016 Apr;8(4):696-704. doi: 10.21037/jtd.2016.03.31.
2
Thymic epithelial tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.胸腺上皮肿瘤：ESMO诊断、治疗及随访临床实践指南
Ann Oncol. 2015 Sep;26 Suppl 5:v40-55. doi: 10.1093/annonc/mdv277.
3
The 2015 World Health Organization Classification of Tumors of the Thymus: Continuity and Changes.《2015年世界卫生组织胸腺肿瘤分类：延续性与变化》
J Thorac Oncol. 2015 Oct;10(10):1383-95. doi: 10.1097/JTO.0000000000000654.
4
Thymic carcinoma outcomes and prognosis: results of an international analysis.胸腺癌的结局和预后：国际分析结果。
J Thorac Cardiovasc Surg. 2015 Jan;149(1):95-100, 101.e1-2. doi: 10.1016/j.jtcvs.2014.09.124. Epub 2014 Oct 5.
5
Thymic carcinoma: a cohort study of patients from the European society of thoracic surgeons database.胸腺癌：欧洲胸外科医师学会数据库的患者队列研究。
J Thorac Oncol. 2014 Apr;9(4):541-8. doi: 10.1097/JTO.0000000000000128.
6
Chemotherapy definitions and policies for thymic malignancies.胸腺恶性肿瘤的化疗定义与政策
J Thorac Oncol. 2011 Jul;6(7 Suppl 3):S1749-55. doi: 10.1097/JTO.0b013e31821ea5f7.
7
The Masaoka-Koga stage classification for thymic malignancies: clarification and definition of terms.胸腺恶性肿瘤的Masaoka-Koga分期分类：术语的阐释与定义
J Thorac Oncol. 2011 Jul;6(7 Suppl 3):S1710-6. doi: 10.1097/JTO.0b013e31821e8cff.
8
Phase II study of a multidisciplinary approach with induction chemotherapy, followed by surgical resection, radiation therapy, and consolidation chemotherapy for unresectable malignant thymomas: final report.不可切除恶性胸腺瘤多学科治疗方案（诱导化疗后行手术切除、放射治疗及巩固化疗）的II期研究：最终报告
Lung Cancer. 2004 Jun;44(3):369-79. doi: 10.1016/j.lungcan.2003.12.010.
Zotero 插件